搜索结果21-30 的 834 / anti-TNF drugs

  1. 非甾体抗炎药：会增加心脏病发作和卒中的风险吗？ - 妙佑医疗国际

    FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes.

  2. 泌尿科- 临床试验- 妙佑医疗国际

    A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...

  3. 放射科- 临床试验- 妙佑医疗国际

    Chemotherapy drugs, such as capecitabine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by ...

  4. 神经科- 临床试验- 妙佑医疗国际

    Drugs used in chemotherapy, such as cisplatin, vincristine sulfate, cyclophosphamide and lomustine, work in different ways to stop the growth of tumor cells ...

  5. 内分泌科- 临床试验- 妙佑医疗国际

    Chemotherapy drugs, such as capecitabine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by ...

  6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's transformation, and ...

  7. Senescent cells Promising anti-aging targets for health span extension and the treatment of osteoporosis - 妙佑医疗国际

    Senescent cells Promising anti-aging targets for health span extension and the treatment of osteoporosis. MAC-20431073.

  8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Pertuzumab and trastuzumab are monoclonal antibodies and forms of targeted therapy that attach to a receptor protein called human epidermal growth factor ...

  9. 性能增强药物：明确风险- 妙佑医疗国际

    11, 2018. Effects of performance-enhancing drugs. U.S. Anti-Doping Agency. https://www.usada.org/substances/effects-of-performance-enhancing-drugs/. Accessed ...

  10. 神经科- 临床试验- 妙佑医疗国际

    This phase II trial studies the side effects and how well pembrolizumab works in combination with standard therapy in treating patients with glioblastoma. Drugs ...